Kasturi001 (Talk | contribs) |
Kasturi001 (Talk | contribs) |
||
Line 24: | Line 24: | ||
<div id='groupparts' style='min-height:100px;width:1084px;margin:auto;'><div style='width:300px;margin:auto;padding:20px;color:gray;border:1px solid gray'>Loading…..</div></div><script>$('#groupparts').load('/cgi/api/groupparts.cgi', { t:'iGEM2017', g:'NTU_Singapore' },function(){ $('#groupparts .tablesorter').tablesorter();} );</script> | <div id='groupparts' style='min-height:100px;width:1084px;margin:auto;'><div style='width:300px;margin:auto;padding:20px;color:gray;border:1px solid gray'>Loading…..</div></div><script>$('#groupparts').load('/cgi/api/groupparts.cgi', { t:'iGEM2017', g:'NTU_Singapore' },function(){ $('#groupparts .tablesorter').tablesorter();} );</script> | ||
+ | <h3> Enhanced Part </h3> | ||
+ | <h2>∆RuvCIII-2 ∆HNH ∆REC2 Sp-dCas9 Enhanced</h2> | ||
+ | <p>dCas9 is a catalytically inactive Cas9, which still retains it's ability to bind to DNA. For epigenetic regulation, the dCas9 is highly dependent upon the function of it's fusion partner.</p> | ||
+ | <p> | ||
</div> | </div> |
Revision as of 18:16, 31 October 2017